165 related articles for article (PubMed ID: 35098855)
1. Containment strategies for COVID-19 in India: lessons from the second wave.
Asrani P; Tiwari K; Eapen MS; Hassan MDI; Sohal SS
Expert Rev Anti Infect Ther; 2022 Jun; 20(6):829-835. PubMed ID: 35098855
[TBL] [Abstract][Full Text] [Related]
2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
3. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
4. Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics.
Jacob JJ; John Fletcher G; Monisha Priya T; Veeraraghavan B; Mutreja A
Indian J Med Microbiol; 2021; 39(4):417-422. PubMed ID: 34454775
[TBL] [Abstract][Full Text] [Related]
5. Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe.
Thakur V; Bhola S; Thakur P; Patel SKS; Kulshrestha S; Ratho RK; Kumar P
Infection; 2022 Apr; 50(2):309-325. PubMed ID: 34914036
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
[TBL] [Abstract][Full Text] [Related]
7. Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India.
Yadav PD; Kumar G; Mukherjee A; Nyayanit DA; Shete AM; Sahay RR; Kumar A; Majumdar T; Patil S; Pandit P; Joshi Y; Dudhmal M; Panda S; Sharma LK; Yadav Ml K; Shastri J; Gangwar M; Munivenkattapa A; Potdar V; Nagamani K; Goyal K; Gadepalli R; Thomas M; Shukla S; Nagraj P; Gupta V; Dalela G; Umar N; Patel SM
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1060-1068. PubMed ID: 35843834
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of the second and third wave of the Covid-19 pandemic: an experience from a tertiary care hospital in Western India.
Swami A; Mohanty A; Jamwal A; Turbadkar D; Baveja S; Shastri J; Chitalia V
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37171852
[No Abstract] [Full Text] [Related]
9. Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.
Kim JM; Rhee JE; Yoo M; Kim HM; Lee NJ; Woo SH; Jo HJ; Kwon D; Lee S; Yoo CK; Kim EJ
Front Microbiol; 2022; 13():819745. PubMed ID: 35308391
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.
Desai D; Khan AR; Soneja M; Mittal A; Naik S; Kodan P; Mandal A; Maher GT; Kumar R; Agarwal A; Gowda NR; H V; Kumar P; Pandey S; Pandey RM; Kumar A; Ray A; Jorwal P; Nischal N; Choudhary A; Brijwal M; Madan K; Lodha R; Sinha S; Dar L; Wig N; Guleria R
Lancet Infect Dis; 2022 Mar; 22(3):349-356. PubMed ID: 34826383
[TBL] [Abstract][Full Text] [Related]
11. B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies.
Zhan Y; Yin H; Yin JY
Int J Biol Sci; 2022; 18(5):1844-1851. PubMed ID: 35342345
[TBL] [Abstract][Full Text] [Related]
12. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
Lee BU
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
[TBL] [Abstract][Full Text] [Related]
13. Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India.
Singh J; Malhotra AG; Biswas D; Shankar P; Lokhande L; Yadav AK; Raghuvanshi A; Kale D; Nema S; Saigal S; Singh S
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828410
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of novel Corona Virus (severe acute respiratory syndrome Coronavirus 2) and its uncertain future in the different regions of Punjab.
Sidhu SK; Singh K; Tuli AK; Bigdelitabar S; Jairath M
Indian J Public Health; 2022; 66(1):45-48. PubMed ID: 35381713
[TBL] [Abstract][Full Text] [Related]
15. The Pandemic, Infodemic, and People's Resilience in India: Viewpoint.
Syed Abdul S; Ramaswamy M; Fernandez-Luque L; John O; Pitti T; Parashar B
JMIR Public Health Surveill; 2021 Dec; 7(12):e31645. PubMed ID: 34787574
[TBL] [Abstract][Full Text] [Related]
16. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
[TBL] [Abstract][Full Text] [Related]
17. Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario.
Suvvari TK; P C; Kuppili S; Kandi V; Kutikuppala LVS; Kandula VDK; Mishra S; Sarangi AK; Mohapatra RK; Dhama K
Arch Razi Inst; 2021 Nov; 76(5):1165-1174. PubMed ID: 35355747
[TBL] [Abstract][Full Text] [Related]
18. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
Chatterjee P; Anand T; Singh KJ; Rasaily R; Singh R; Das S; Singh H; Praharaj I; Gangakhedkar RR; Bhargava B; Panda S
Indian J Med Res; 2020 May; 151(5):459-467. PubMed ID: 32611916
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
Sharma D
Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
